Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry

Authors :: Isa F. Ashoor, MD
Karen Martz, MS
Shirley Galbiati, MS
Robbie A. Beyl, PhD
Vikas R. Dharnidharka, MD, MPH
on behalf of the NAPRTCS Investigators
Source :: Transplantation Direct, Vol 6, Iss 9, p e598 (2020)
Publication Year :: 2020
Publisher :: Wolters Kluwer, 2020.
Abstract: Background. There is no consensus on rabbit antithymocyte globulin (rATG) dose used for induction immunosuppression in pediatric kidney transplants. We aimed to identify whether a lower rATG dose provides safe and effective immunosuppression compared with a higher dose. Methods. We retrospectively analyzed all first-time kidney transplant recipients (aged

Full Text Access

Tools